These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 19743648

  • 1. Jay Crowley the FDA's perspective on the unique device identification system.
    Crowley J.
    Healthc Financ Manage; 2009 Sep; 63(9):48-51. PubMed ID: 19743648
    [No Abstract] [Full Text] [Related]

  • 2. Jane Pleasants a provider's perspective on the unique device identification system.
    Pleasants J.
    Healthc Financ Manage; 2009 Sep; 63(9):52-3. PubMed ID: 19743649
    [No Abstract] [Full Text] [Related]

  • 3. ECRI comments on FDA's reuse plan.
    Healthc Hazard Manage Monit; 2000 Jun; 13(10):4-5. PubMed ID: 11125912
    [No Abstract] [Full Text] [Related]

  • 4. Using the FDA's Device Experience Network.
    Collins JL.
    Oncol Nurs Forum; 1992 Apr; 19(3):524. PubMed ID: 1594477
    [No Abstract] [Full Text] [Related]

  • 5. FDA's medical device standards policy.
    Stimson RA.
    J Parenter Sci Technol; 1981 Apr; 35(2):60-2. PubMed ID: 7229834
    [No Abstract] [Full Text] [Related]

  • 6. Process of elimination. Know what to ask when choosing a third-party reprocessor.
    Furman PJ.
    Mater Manag Health Care; 2002 Mar; 11(3):22-4. PubMed ID: 11925673
    [No Abstract] [Full Text] [Related]

  • 7. The industry's take on data standards.
    Nachtmann H, Pohl E.
    Mater Manag Health Care; 2009 Mar; 18(3):12-6. PubMed ID: 19385273
    [No Abstract] [Full Text] [Related]

  • 8. Disinfection guidelines: the great debate.
    Souhrada L.
    Mater Manag Health Care; 1997 Mar; 6(3):40, 42, 44. PubMed ID: 10165578
    [No Abstract] [Full Text] [Related]

  • 9. Is FDA's medical device evaluation process overly complaisant to industry?
    Margolis RE.
    Healthspan; 1992 Mar; 9(7):19-20. PubMed ID: 10121440
    [No Abstract] [Full Text] [Related]

  • 10. Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder.
    Fins JJ, Mayberg HS, Nuttin B, Kubu CS, Galert T, Sturm V, Stoppenbrink K, Merkel R, Schlaepfer TE.
    Health Aff (Millwood); 2011 Feb; 30(2):302-11. PubMed ID: 21289352
    [Abstract] [Full Text] [Related]

  • 11. FDA's Quality System Inspection Technique in Ireland.
    Higgins S.
    Med Device Technol; 2001 Feb; 12(1):40-1. PubMed ID: 11317865
    [No Abstract] [Full Text] [Related]

  • 12. The FDA's response to the GAO's report: new effort to tighten the pre-market review process for select Class III medical devices.
    Kim JH, Smith J, Greis J, Werling K.
    Health Care Law Mon; 2009 May; 2009(5):2-8. PubMed ID: 19449776
    [No Abstract] [Full Text] [Related]

  • 13. FDA issues Unique Device Identification final rule.
    Mathias JM.
    OR Manager; 2013 Nov; 29(11):5, 26. PubMed ID: 24298669
    [No Abstract] [Full Text] [Related]

  • 14. FDA's developing standards policy.
    Link DM.
    Med Instrum; 1979 Nov; 13(4):196-7. PubMed ID: 470656
    [No Abstract] [Full Text] [Related]

  • 15. Solve a unique challenge. Product identifiers get industrywide attention.
    DiConsiglio J.
    Mater Manag Health Care; 2007 Sep; 16(9):24-8, 30. PubMed ID: 17955920
    [No Abstract] [Full Text] [Related]

  • 16. The FDA's policy on the regulation of computerized medical devices.
    Furfine CS.
    MD Comput; 1992 Sep; 9(2):97-100. PubMed ID: 1573995
    [No Abstract] [Full Text] [Related]

  • 17. ECRI to clinical engineering departments: "heads up! ... FDA's potential regulation of servicers, remarketers, and refurbishers could affect you".
    Health Devices; 1998 Aug; 27(8):276. PubMed ID: 9743899
    [No Abstract] [Full Text] [Related]

  • 18. Voluntary consensus standards and the FDA's regulatory program.
    Gardner S.
    Med Instrum; 1979 Aug; 13(4):239-42. PubMed ID: 470665
    [No Abstract] [Full Text] [Related]

  • 19. Problems in sterile devices. The FDA's view of the problem.
    Butts HE.
    Hosp Manage; 1971 Apr; 111(4):37. PubMed ID: 16329343
    [No Abstract] [Full Text] [Related]

  • 20. FDA's focus on consensus standards: the vision, the heartbreak, the hope.
    Altman MR, Marlowe DE.
    Stand News; 1999 May; 27(5):24-5. PubMed ID: 10558422
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.